Christine Lennon
Profile
Christine Lennon is Vice President of Business Development for Bellus Health, Inc. She was Venture Advisor for the Biotechnology and Life Sciences investment sector of CDP Capital-Technology Ventures.
Ms. Lennon joined BioChem Pharma, Inc. as Director of Investor Relations in May 1994 and had been Vice President of Corporate Communications and Investor Relations since 1996 and Vice President of Global Commercial Development-Oncology since 1999.
She began her career at Sandoz Canada, Inc. Ms. Lennon received an MBA and a Bachelor's degree in Science, Honors from McGill University.
Former positions of Christine Lennon
| Companies | Position | End |
|---|---|---|
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Corporate Officer/Principal | - |
| BELLUS HEALTH | Corporate Officer/Principal | - |
Training of Christine Lennon
| McGill University | Masters Business Admin |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Biochem Pharma, Inc.
Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
- Stock Market
- Insiders
- Christine Lennon
